RCMI Coordinating Center (RCMI CC) Header Logo

Vakaramoko Diaby

TitleAssistant Professor
InstitutionFlorida A&M University
DepartmentCollege of Pharmacy and Pharmaceutical Sciences
Address1520 S MLK Jr. Blvd
Dyson Building Room 200 G
Tallahassee FL 32307
Phone8504125712
Fax8504127548
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Diaby V, Almutairi RD, Chen Z, Moussa RK, Berthe A. A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19. Expert Rev Pharmacoecon Outcomes Res. 2020 Dec 08; 1-9. PMID: 33186061.
      Citations:    Fields:    
    2. Diaby V, Almutairi RD, Babcock A, Moussa RK, Ali A. Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews. Expert Rev Pharmacoecon Outcomes Res. 2020 Dec 01; 1-12. PMID: 33213205.
      Citations:    Fields:    
    3. Okere AN, Sanogo V, Alqhtani H, Diaby V. Identification of risk factors of 30-day readmission and 180-day in-hospital mortality, and its corresponding relative importance in patients with Ischemic heart disease: a machine learning approach. Expert Rev Pharmacoecon Outcomes Res. 2020 Nov 11; 1-6. PMID: 33131344.
      Citations:    Fields:    
    4. Huo J, Hong YR, Turner K, Diaby V, Chen C, Bian J, Grewal R, Wilkie DJ. Timing, Costs, and Survival Outcome of Specialty Palliative Care in Medicare Beneficiaries With Metastatic Non-Small-Cell Lung Cancer. JCO Oncol Pract. 2020 Dec; 16(12):e1532-e1542. PMID: 33006914.
      Citations:    
    5. Tran AD, Fogarty G, Nowak AK, Diaby V, Hong A, Watts C, Morton RL. Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases. Appl Health Econ Health Policy. 2020 10; 18(5):679-687. PMID: 32157631.
      Citations:    Fields:    
    6. Babcock A, Moussa RK, Diaby V. Prevalence and effects of suicidal ideation diagnosis code position in claims on readmission rate estimates. Res Social Adm Pharm. 2020 Sep 08. PMID: 32928656.
      Citations:    Fields:    
    7. Ding DD, Balkrishnan R, Diaby V. In our war against the opioid epidemic, could 'weed' be a winner? Expert Rev Pharmacoecon Outcomes Res. 2020 Oct; 20(5):423-429. PMID: 32799573.
      Citations:    Fields:    
    8. Babcock A, Ali AA, Balkrishnan R, Montero A, Diaby V. Real-World Clinical and Economic Outcomes Associated with Palbociclib for HR-Positive/HER2 Negative Metastatic Breast Cancer: A Commentary. J Manag Care Spec Pharm. 2020 Jul; 26(7):826-831. PMID: 32584682.
      Citations:    Fields:    
    9. Nkemdirim Okere A, Sanogo V, Balkrishnan R, Diaby V. A quantitative analysis of the effect of continuity of care on 30-day readmission and in-hospital mortality among patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2020 Sep; 29(9):105053. PMID: 32807459.
      Citations:    Fields:    Translation:Humans
    10. Moussa RK, Diaby V. Self-assessed life expectancy among older adults in Côte d'Ivoire. BMC Public Health. 2020 Jun 15; 20(1):932. PMID: 32539697.
      Citations:    Fields:    Translation:Humans
    11. Wang CY, Pham PN, Kim S, Lingineni K, Schmidt S, Diaby V, Brown J. Predicting Cost-Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United States. Clin Transl Sci. 2020 03; 13(2):352-361. PMID: 32053288.
      Citations:    Fields:    
    12. Limdi NA, Cavallari LH, Lee CR, Hillegass WB, Holmes AM, Skaar TC, Pisu M, Dillon C, Beitelshees AL, Empey PE, Duarte JD, Diaby V, Gong Y, Johnson JA, Graves J, Garbett S, Zhou Z, Peterson JF. Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data. Pharmacogenomics J. 2020 10; 20(5):724-735. PMID: 32042096.
      Citations: 1     Fields:    
    13. Tran PT, Diaby V. Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer. J Manag Care Spec Pharm. 2020 Feb; 26(2):221. PMID: 32011959.
      Citations:    Fields:    Translation:Humans
    14. Diaby V, Wang CY, Alqhtani H, van Boemmel-Wegmann S, Ali AA, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G. Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting. Data Brief. 2020 Apr; 29:105194. PMID: 32071975.
      Citations:    
    15. Diaby V, Alqhtani H, van Boemmel-Wegmann S, Wang CY, Ali AA, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G. A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan. Breast. 2020 Feb; 49:141-148. PMID: 31805500.
      Citations: 2     Fields:    Translation:Humans
    16. Xiao H, Jiang X, Chen C, Wang W, Wang CY, Ali AA, Berthe A, Moussa RK, Diaby V. Using time series analysis to forecast the health-related quality of life of post-menopausal women with non-metastatic ER+ breast cancer: A tutorial and case study. Res Social Adm Pharm. 2020 Aug; 16(8):1095-1099. PMID: 31753693.
      Citations:    Fields:    
    17. Baltussen R, Marsh K, Thokala P, Diaby V, Castro H, Cleemput I, Garau M, Iskrov G, Olyaeemanesh A, Mirelman A, Mobinizadeh M, Morton A, Tringali M, van Til J, Valentim J, Wagner M, Youngkong S, Zah V, Toll A, Jansen M, Bijlmakers L, Oortwijn W, Broekhuizen H. Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward. Value Health. 2019 11; 22(11):1283-1288. PMID: 31708065.
      Citations: 4     Fields:    Translation:Humans
    18. Shah CH, Balkrishnan R, Diaby V, Xiao H. Examining factors associated with adherence to hormonal therapy in breast cancer patients. Res Social Adm Pharm. 2020 04; 16(4):574-582. PMID: 31473108.
      Citations:    Fields:    
    19. Diaby V, Ali AA, Montero AJ. Value Assessment Frameworks in the United States: A Call for Patient Engagement. Pharmacoecon Open. 2019 Mar; 3(1):1-3. PMID: 30182346.
      Citations:    
    20. Ali AA, Tawk R, Xiao H, Campbell E, Semykina A, Montero AJ, Mogos M, Diaby V. Comparative effectiveness of radiotherapy for early-stage hormone receptor-positive breast cancer in elderly women using real-world data. Cancer Med. 2019 01; 8(1):117-127. PMID: 30548840.
      Citations:    Fields:    Translation:Humans
    21. Xiao H, Jiang X, Chen C, Montero AJ, Diaby V. Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER+ Breast Cancer: A Systematic Review. Pharmacoecon Open. 2018 Dec; 2(4):359-369. PMID: 29470807.
      Citations:    
    22. Okere AN, Ezendu K, Berthe A, Diaby V. An Evaluation of the Cost-effectiveness of Comprehensive MTM Integrated with Point-of-Care Phenotypic and Genetic Testing for U.S. Elderly Patients After Percutaneous Coronary Intervention. J Manag Care Spec Pharm. 2018 Feb; 24(2):142-152. PMID: 29384027.
      Citations:    Fields:    Translation:Humans
    23. Okere AN, Montesdeoca J, Glasper A, Diaby V. An Evaluation of the Clinical Therapeutic Effect of Lixisenatide in Type 2 Diabetes Patients: A Systematic Literature Review. Curr Diabetes Rev. 2018; 14(4):363-375. PMID: 28738763.
      Citations: 1     Fields:    Translation:HumansCells
    24. Diaby V, Ali AA, Williams KJ, Ezendu K, Soto-Perez-de-Celis E, Chavarri-Guerra Y, de Lima Lopes G. Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives. Breast Cancer Res Treat. 2017 Dec; 166(3):951-963. PMID: 28840424.
      Citations: 2     Fields:    Translation:Humans
    25. Ali AA, Xiao H, Tawk R, Campbell E, Semykina A, Montero AJ, Diaby V. Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy. Curr Med Res Opin. 2017 02; 33(2):391-400. PMID: 27819160.
      Citations: 1     Fields:    Translation:Humans
    26. Diaby V, Adunlin G, Ali AA, Zeichner SB, de Lima Lopes G, Kohn CG, Montero AJ. Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States. Breast Cancer Res Treat. 2016 11; 160(1):187-196. PMID: 27654970.
      Citations: 5     Fields:    Translation:Humans
    27. Boulin M, Diaby V, Tannenbaum C. Preventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and Canada. PLoS One. 2016; 11(9):e0162951. PMID: 27648831.
      Citations: 3     Fields:    Translation:Humans
    28. Diaby V, Ali AA, Adunlin G, Kohn CG, Montero AJ. Parameterization of a disease progression simulation model for sequentially treated metastatic human epidermal growth factor receptor 2 positive breast cancer patients. Curr Med Res Opin. 2016 06; 32(6):991-6. PMID: 26824145.
      Citations: 4     Fields:    Translation:Humans
    29. Diaby V, Sanogo V, Moussa KR. ELICIT: An alternative imprecise weight elicitation technique for use in multi-criteria decision analysis for healthcare. Expert Rev Pharmacoecon Outcomes Res. 2016; 16(1):141-7. PMID: 26361235.
      Citations: 1     Fields:    Translation:Humans
    30. Diaby V, Tawk R, Sanogo V, Xiao H, Montero AJ. A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer. Breast Cancer Res Treat. 2015 May; 151(1):27-40. PMID: 25893588.
      Citations: 20     Fields:    Translation:Humans
    31. Tannenbaum C, Diaby V, Singh D, Perreault S, Luc M, Vasiliadis HM. Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US Medicare perspective. Drugs Aging. 2015 Apr; 32(4):305-14. PMID: 25825121.
      Citations: 13     Fields:    Translation:Humans
    32. Adunlin G, Diaby V, Xiao H. Application of multicriteria decision analysis in health care: a systematic review and bibliometric analysis. Health Expect. 2015 Dec; 18(6):1894-905. PMID: 25327341.
      Citations: 19     Fields:    Translation:Humans
    33. Diaby V, Goeree R, Hoch J, Siebert U. Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion. Expert Rev Pharmacoecon Outcomes Res. 2015 Feb; 15(1):13-9. PMID: 25267699.
      Citations: 5     Fields:    Translation:Humans
    34. Diaby V, Adunlin G, Ali AA, Tawk R. Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial. Breast Cancer Res Treat. 2014 Aug; 146(3):669-73. PMID: 25017612.
      Citations: 5     Fields:    Translation:Humans
    35. Diaby V, Adunlin G, Zeichner SB, Avancha K, Lopes G, Gluck S, Montero AJ. Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer. Breast Cancer Res Treat. 2014 Sep; 147(2):433-41. PMID: 25012857.
      Citations: 5     Fields:    Translation:Humans
    36. Adunlin G, Diaby V, Montero AJ, Xiao H. Multicriteria decision analysis in oncology. Health Expect. 2015 Dec; 18(6):1812-26. PMID: 24635949.
      Citations: 4     Fields:    Translation:Humans
    37. Diaby V, Adunlin G, Montero AJ. Re: Xie J, Diener M, De G, et al. Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in the United States. J Med Econ 2014;16(2):278-88. J Med Econ. 2014 Apr; 17(4):248-9. PMID: 24506762.
      Citations:    Fields:    Translation:Humans
    38. Diaby V, Adunlin G, Montero AJ. Survival modeling for the estimation of transition probabilities in model-based economic evaluations in the absence of individual patient data: a tutorial. Pharmacoeconomics. 2014 Feb; 32(2):101-8. PMID: 24338265.
      Citations: 17     Fields:    Translation:Humans
    39. Diaby V, Goeree R. How to use multi-criteria decision analysis methods for reimbursement decision-making in healthcare: a step-by-step guide. Expert Rev Pharmacoecon Outcomes Res. 2014 Feb; 14(1):81-99. PMID: 24328890.
      Citations: 12     Fields:    Translation:Humans
    40. Goeree R, Diaby V. Introduction to health economics and decision-making: Is economics relevant for the frontline clinician? Best Pract Res Clin Gastroenterol. 2013 Dec; 27(6):831-44. PMID: 24182604.
      Citations: 6     Fields:    Translation:Humans
    41. Diaby V, Lachaine J. An application of a proposed framework for formulary listing in low-income countries: the case of Côte d'Ivoire. Appl Health Econ Health Policy. 2011 Nov 01; 9(6):389-402. PMID: 22017499.
      Citations: 6     Fields:    Translation:Humans
    42. Diaby V, Dié Kakou H, Lachaine J. Eliciting preferences for reimbursed drugs selection criteria in Côte d'Ivoire. Patient. 2011; 4(2):125-31. PMID: 21766901.
      Citations: 2     Fields:    Translation:Humans
    43. Diaby V, Perreault S, Lachaine J. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women. Maturitas. 2007 Oct 20; 58(2):138-49. PMID: 17870259.
      Citations:    Fields:    Translation:Humans
    Diaby's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (140)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support